This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Seed Company Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Hideyuki Otake
Introduction
Hideyuki Otake is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of contact lens solutions, focusing on enhancing safety and versatility for users. His work is particularly relevant for individuals who rely on contact lenses for vision correction.
Latest Patents
Otake holds a patent for an innovative Anti-Acanthamoeba contact lens solution. The objective of this invention is to provide a contact lens solution that is safer for the eyes, minimizing any adverse effects on eye tissue. The solution is designed to be applicable to a wide range of contact lenses while exhibiting desirable anti-activity. This is achieved through the use of a cationic polymer with an average molecular weight ranging from 150,000 to 1,600,000, which includes a diallyldimethylammonium chloride unit and an inorganic salt.
Career Highlights
Otake is associated with Seed Company Limited, where he continues to develop innovative solutions in the field of eye care. His dedication to improving contact lens safety has positioned him as a key figure in this industry.
Collaborations
Otake has worked alongside talented colleagues, including Yoshinori Yanagawa and Hiroyuki Nawase. Their collaborative efforts contribute to the advancement of technology in contact lens solutions.
Conclusion
Hideyuki Otake's contributions to the field of contact lens solutions highlight his commitment to innovation and safety. His patent for the Anti-Acanthamoeba contact lens solution represents a significant advancement in eye care technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
